داروسازی امین
دامین | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 17,280 2.98
Close Price: 17,280
Financial Ratios
AGM
Interim
2026/02/28 Fiscal Year 2025/12/2112 Month | 2025/07/09 Fiscal Year 2025/03/2012 Month | 2024/06/10 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 9.22 | 8.6 | 23.37 | |
Gross Profit to Sales | 11.78 | 10.02 | 27.05 | |
Operating Margin | 33.44 | 23.72 | 34.93 | |
Gross Profit to Sales | 41.57 | 32.33 | 40.54 | |
Net Profit to Gross Profit | 22.19 | 26.61 | 57.63 | |
Return on Assets (ROA) | 3.11 | 4.92 | 13.04 | |
Return on Capital (%) | 9.08 | 20.67 | 52.64 | |
Return on Equity (ROE) | 7.08 | 10.34 | 27.09 | |
Working Capital Return | 10.77 | 18.17 | 44.35 | |
Fixed Asset Return | 13.75 | 23.08 | 64.87 | |
Loan Benefit Assessment | 2.27 | 2.1 | 2.08 | |
Current Ratio | 1.6 | 1.53 | 1.59 | |
Quick Ratio | 1.22 | 1.05 | 1.2 | |
Liquidity Ratio | 0.41 | 0.03 | 0.18 | |
Net Working Capital | 7,692,277 | 6,258,432 | 6,527,703 | |
Current Assets Ratio | 0.77 | 0.78 | 0.8 | |
Inventory Turnover | 368.95 | 202.94 | 191.72 | |
Receivables Collection Period | 388.02 | 313.52 | 279.38 | |
Inventory to Working Capital | 0.64 | 0.91 | 0.65 | |
Working Capital Turnover | 1.17 | 2.11 | 1.9 | |
Fixed Asset Turnover | 1.49 | 2.68 | 2.78 | |
Total Asset Turnover | 0.34 | 0.57 | 0.56 | |
Debt Ratio | 0.56 | 0.52 | 0.52 | |
Debt to Equity | 1.27 | 1.1 | 1.08 | |
Long-Term Debt to Equity | 0.18 | 0.03 | 0.04 | |
Current Debt to Equity | 1.09 | 1.08 | 1.04 | |
Equity Ratio | 43.99 | 47.53 | 48.15 | |
Debt Coverage Ratio | 2.84 | 16.23 | 11.93 |